Access Bio Inc (950130) — Cash Flow Quality Index
Access Bio Inc (950130) has a Cash Flow Quality Index of -6.44x as of June 2024. Operating cash flow of ₩-9.83 Billion is below net income of ₩1.53 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Access Bio Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Access Bio Inc Cash Flow Quality Index (2012–2022)
Historical Cash Flow Quality Index for Access Bio Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Access Bio Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Access Bio Inc (2012–2022)
Year-by-year earnings quality comparison for Access Bio Inc. For live market cap and the full company financial profile, see Access Bio Inc (950130) market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.00x | ₩291.33 Million | ₩346.67 Billion | ▲ +15.6% |
| 2021 | 0.00x | ₩137.90 Million | ₩189.69 Billion | ▼ -99.9% |
| 2020 | 0.76x | ₩36.72 Billion | ₩48.27 Billion | ▼ -66.4% |
| 2015 | 2.26x | ₩2.87 Billion | ₩1.27 Billion | ▲ +309.1% |
| 2014 | -1.08x | ₩-2.63 Billion | ₩2.43 Billion | ▼ -634.9% |
| 2013 | 0.20x | ₩1.59 Billion | ₩7.84 Billion | ▼ -18.3% |
| 2012 | 0.25x | ₩1.85 Billion | ₩7.45 Billion | — |